StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
XXII

22nd Century Group, Inc.

XXII Nasdaq Cigarettes EDGAR ↗
$0.80
-0.15 -16.04%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$572K
Revenue (TTM) ⓘ
$14.5M
Net income (TTM) ⓘ
-$3.93M
EPS (TTM) ⓘ
$4,053.53
P/E ratio ⓘ
0.0
Dividend yield ⓘ
—
Free cash flow ⓘ
-$7.78M
Cash ⓘ
$6.06M
Total assets ⓘ
$26.2M
Gross margin ⓘ
2.8%
52-week range ⓘ
$0.79 – $540.00

AI briefing

from the latest 10-K, 10-Q and 8-K events

22nd Century Group is a tobacco products company selling FDA-authorized reduced-nicotine VLN cigarettes and contract-manufacturing conventional cigarettes and filtered cigars, at roughly $2.9 million of quarterly revenue.

What they do

The company manufactures and distributes combustible tobacco products containing 95% less nicotine than conventional cigarettes, marketed under the VLN brand and, since 2025, under a Pinnacle brand portfolio. It received FDA Modified Risk Tobacco Product granted orders in December 2021 for its reduced nicotine content (RNC) cigarettes, which the filing describes as the first and only such orders awarded for a combusted tobacco product. In parallel it runs contract manufacturing operations (CMO) producing branded filtered cigars and conventional cigarettes for other tobacco brands, and it is a subsequent participating manufacturer under the Master Settlement Agreement.

Revenue drivers

  • Contract manufacturing operations (CMO) — Turnkey manufacturing of cigarettes and filtered cigars for established tobacco brands, including export customers. The second-quarter 2026 revenue decline was attributed primarily to a strategic shift away from high-volume, low-priced CMO export customers, indicating CMO has been the larger but lower-margin revenue base.
  • VLN and Pinnacle reduced-nicotine cigarettes — FDA-authorized 95%-less-nicotine combustible cigarettes sold through third-party retail. Distribution has been built through a store footprint spanning more than 5,000 stores in 26 states as of the 10-K, with 2026 additions in metro New York, northern New Jersey and California.
  • Partner or flanker brand strategy — The company manufactures VLN versions of cigarette brands it already produces for existing clients and sells them through those clients' distribution channels, described in the 10-K as a way to leverage CMO relationships for volume growth and retail access.

Recent performance

Second-quarter 2026 net revenues were $2.864 million, down 29.9% from $4.083 million in the prior-year period, with cartons sold falling to 151 from 779 on the shift away from low-priced CMO exports. Gross loss narrowed to $0.293 million from $0.635 million, reflecting a $196 thousand write-off of aged inventory offset by a $692 thousand one-time excise tax adjustment. Operating loss from continuing operations widened to $3.291 million from $2.981 million, and net loss from continuing operations was $3.265 million. Cash and cash equivalents were $6.058 million at June 30, 2026. Full-year revenue has declined each year from $40.5 million in 2022 to $17.6 million in 2025, while net loss narrowed from $140.8 million in 2023 to $5.1 million in 2025.

Strategy

Management's stated 2026 priorities are expanding VLN distribution and consumer awareness, disciplined cost management and capital allocation, advancing toward EBITDA breakeven as higher-margin revenue scales, and continued engagement with FDA regulators and public-health stakeholders. The commercial approach shifted in 2025 toward creating VLN versions of popular cigarette brands already manufactured for existing clients and selling them through those clients' channels, rather than positioning VLN solely as a standalone novel product. The company describes building a 'House of Brands' of proprietary and partner flanker brands to increase shelf visibility and volume. Recent launches include Pinnacle Pure for more than 2,000 retail locations and Pinnacle VLN in approximately 150 additional metro New York and northern New Jersey stores plus about 60 California stores.

Risks

  • Going concern — The 10-K states there is substantial doubt about the ability to continue as a going concern, and the company needs additional funding to execute its business plan and service obligations.
  • Regulatory removal or non-approval — The FDA could force removal of the company's products from the U.S. market, and states or the National Association of Attorneys General may not approve its products in certain states.
  • Customer concentration — The company cites risk that loss of a significant customer for whom it manufactures tobacco products could adversely affect results, a live exposure given the CMO revenue base.
  • Nasdaq listing and dilution — The company may be unable to remain listed on the Nasdaq stock market, and the 10-K notes future sales of common stock will result in dilution to stockholders.

Outlook

Management says it will continue expanding national VLN distribution in 2026, referencing the approximately 270,000 domestic tobacco retail outlets and the estimated $58 billion U.S. combustible cigarette market. It targets progress toward EBITDA breakeven as higher-margin revenue scales, supported by new Pinnacle products and additional partner-brand opportunities. No specific revenue or earnings guidance is provided in the excerpts, and the 10-K reiterates that losses are expected to continue for the foreseeable future.

Recent SEC filings

40 most recent
Annual, quarterly & current reports